FDA Inspection 1253473 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Oct 24, 2024 in Decatur, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Decatur, GA (United States)